Member Info for Bella6532

Energy...they'd better be thinking a much higher number than our current market cap...no way would I want to sell for today's MC...

Just in case anyone pays attention to charts, we appear to be in about the same position as we were on 23 December 2020 and the past month has followed almost an identical pathway...but hey, that's past and this is now...

Ray...airports think Calibre not Medusa

Late 122 trade last night makes it look like we've dropped this morning...not so...all smoke and mirrors going into Thursday.
There will be an RNS at 0700 on Thursday...without doubt..for sure..definitely..trust me on that...
Will there be a second to support both Presentations...my guess is..possibly.
The interim are for business through end June 2021. There could be a forward looking statement and/or post period events but these are not the same as an RNS announcing something important/materially significant. If there is something to be announced then doing in a separate RNS would be better.
If there isn't anything to report separately or any post period updates re partners (see twitter post) then we need to know why not...

Sharpen your pencils guys and gals..get those questions in...even if they don't get answered they will be read and its a way for the company to get an insight into what investors expect from their BOD. Its not all just about AS.

If you are going to relax rules in hospitals etc...and rely on LFTs then accuracy has to be key.

Just a reminder....
'Microbiology Framework
We are proud to announce that Medusa 19 has been approved by the NHS Microbiology Framework Lot 1 for Goods and Services, for the supply of SARS-CoV-2 Lateral Flow Tests throughout the UK.

Medusa 19 are one of multiple selected suppliers to this Framework Contract which will run for the next 4 years and has a value of up to £3 Billion.

This Framework Contract allows the provision to all UK Government Departments and Trusts across England, Scotland, Northern Ireland and Wales subject to access agreement signature and Schedule 6 pricing, to supply the Rapid Saliva Protein Test (RSPT) and Avacta’s professional use AffiDx SARS-CoV-2 Antigen Lateral Flow Tests.

The Medusa tests detailed above and other parties lateral flow tests are now available for purchase by various government departments subject to their demand requirements. '

All depends what you ask and how you ask it!!

And you might find this interesting too..MC2 reckon they've got some pretty high up contacts...
https://www.iprex.com/partner/mc2/

And a bit more info on the Medusa test...
https://thisismc2.com/breakthrough-rapid-saliva-test-launches-in-manchester/

Mr A...yes it was worked up with Cytiva. Perhaps. To be honest..no idea re silence unless having given it to Medusa19 to make/sell they don't feel inclined to talk about it now...perhaps you should get your questions in now for the Presentation on Thursday...

OK so it's from Nov 2020 but still worth a read for those not around then...they clearly state their saliva test was developed by Avacta for those in doubt.
https://flickread.com/edition/html/5f9050269c356#24

Mologic used Advena Ltd, I wonder if Medusa are using them too for HUA/ FDA EUA USA.
https://www.advenamedical.com/

He was with Modern Water up to last year..then moved over to Deepverge...now it appears he's taking on Modern Water position in addition to that at Deepverge.

Percentage of recyclable content is also a requirement for the new Govt approval process isn't it and a big cardboard outer packaging is one way to up the percentage by volume.

The Presentation on 21 June also saw an RNS same day re LFT Distribution Agreement.

With AS also doing an institutional investors presentation at lunchtime on 30 Sept too then there's a good chance Avacta will RNS some news/update on 30th alongside Interims.
BUT...that's just a guess...not fact..and we will all just have to wait and see....

Does our LFT ship in a cardboard box?
If so, is there still a cardboard shortage.
This could explain Calibre having stock but unable to ship.

gje306...as this is a free service, I suspect they just go for the blanket approach...

Doctor100...have you seen some of their advisers...still in nappies most of them with little or no real life experience and many don't even have a driving license - or is it me just getting older...sigh.

Trades are not all they appear to be...

Wonga...they can always add a heading...
Outlook or Post Period

There's no way we're going to avoid partnering with big pharma once our data is published if not before.

https://www.bms.com/business-development/science-and-technology-areas-of-interest.html